Effectiveness of a new bioequivalent formulation of oseltamivir (Enfluvir (R)) on 2010-2011 seasonal influenza viruses: an open phase IV study

CEYHAN, MEHMET; KARADAĞ ÖNCEL, EDA; Badur, Selim; Ciblak, Meral; Alhan, Emre; Celik, Umit; Kurugol, Zafer; SAZ, EYLEM; ÖZSÜREKCİ, YASEMİN; ÇELİK, MELDA; Parlakay, Aslinur

doi:10.1016/j.ijid.2011.12.008

Effectiveness of a new bioequivalent formulation of oseltamivir (Enfluvir (R)) on 2010-2011 seasonal influenza viruses: an open phase IV study

CEYHAN M., KARADAĞ ÖNCEL E., Badur S., Ciblak M. A., Alhan E., Celik U. S., ...Daha Fazla

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, cilt.16, sa.4, 2012 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 16 Sayı: 4
Basım Tarihi: 2012
Doi Numarası: 10.1016/j.ijid.2011.12.008
Dergi Adı: INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Anahtar Kelimeler: Influenza, Children, Symptom duration, Oseltamivir, CHILDREN, BURDEN, HOSPITALIZATION, INFECTION, COMPLICATIONS, EPIDEMIOLOGY, OUTCOMES, THERAPY, ILLNESS, DISEASE
Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
Hacettepe Üniversitesi Adresli: Evet

Özet

Objective: The aim of this multicenter prospective study was to evaluate the efficacy of a new bioequivalent formulation of oseltamivir for the treatment of influenza A, influenza B, and H1N1 during the 2010-2011 influenza season.